chr15-42736313-G-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_138477.4(CDAN1):​c.558C>G​(p.Pro186Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0166 in 1,612,410 control chromosomes in the GnomAD database, including 1,423 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.057 ( 618 hom., cov: 32)
Exomes 𝑓: 0.012 ( 805 hom. )

Consequence

CDAN1
NM_138477.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0420

Publications

6 publications found
Variant links:
Genes affected
CDAN1 (HGNC:1713): (codanin 1) This gene encodes a protein that appears to play a role in nuclear envelope integrity, possibly related to microtubule attachments. Mutations in this gene cause congenital dyserythropoietic anemia type I, a disease resulting in morphological and functional abnormalities of erythropoiesis. [provided by RefSeq, Jul 2009]
CDAN1 Gene-Disease associations (from GenCC):
  • anemia, congenital dyserythropoietic, type 1a
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital dyserythropoietic anemia type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital dyserythropoietic anemia
    Inheritance: AR Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 15-42736313-G-C is Benign according to our data. Variant chr15-42736313-G-C is described in ClinVar as [Benign]. Clinvar id is 262379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.042 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.173 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDAN1NM_138477.4 linkc.558C>G p.Pro186Pro synonymous_variant Exon 2 of 28 ENST00000356231.4 NP_612486.2 Q8IWY9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDAN1ENST00000356231.4 linkc.558C>G p.Pro186Pro synonymous_variant Exon 2 of 28 1 NM_138477.4 ENSP00000348564.3 Q8IWY9-2
CDAN1ENST00000643434.1 linkn.91-232C>G intron_variant Intron 1 of 24 ENSP00000494699.1 A0A2R8Y5C2
CDAN1ENST00000563260.1 linkc.*249C>G downstream_gene_variant 3 ENSP00000455536.1 H3BPZ6

Frequencies

GnomAD3 genomes
AF:
0.0565
AC:
8593
AN:
152026
Hom.:
616
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.176
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0217
Gnomad ASJ
AF:
0.0297
Gnomad EAS
AF:
0.0582
Gnomad SAS
AF:
0.0265
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00507
Gnomad OTH
AF:
0.0411
GnomAD2 exomes
AF:
0.0246
AC:
6059
AN:
246502
AF XY:
0.0225
show subpopulations
Gnomad AFR exome
AF:
0.178
Gnomad AMR exome
AF:
0.00952
Gnomad ASJ exome
AF:
0.0293
Gnomad EAS exome
AF:
0.0649
Gnomad FIN exome
AF:
0.000378
Gnomad NFE exome
AF:
0.00500
Gnomad OTH exome
AF:
0.0176
GnomAD4 exome
AF:
0.0125
AC:
18224
AN:
1460268
Hom.:
805
Cov.:
32
AF XY:
0.0126
AC XY:
9119
AN XY:
726446
show subpopulations
African (AFR)
AF:
0.188
AC:
6301
AN:
33458
American (AMR)
AF:
0.0113
AC:
504
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0324
AC:
845
AN:
26120
East Asian (EAS)
AF:
0.0512
AC:
2033
AN:
39682
South Asian (SAS)
AF:
0.0288
AC:
2485
AN:
86196
European-Finnish (FIN)
AF:
0.000340
AC:
18
AN:
52878
Middle Eastern (MID)
AF:
0.0160
AC:
92
AN:
5764
European-Non Finnish (NFE)
AF:
0.00420
AC:
4670
AN:
1111132
Other (OTH)
AF:
0.0212
AC:
1276
AN:
60324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
940
1881
2821
3762
4702
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0566
AC:
8613
AN:
152142
Hom.:
618
Cov.:
32
AF XY:
0.0547
AC XY:
4068
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.176
AC:
7309
AN:
41504
American (AMR)
AF:
0.0217
AC:
332
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0297
AC:
103
AN:
3470
East Asian (EAS)
AF:
0.0582
AC:
299
AN:
5140
South Asian (SAS)
AF:
0.0268
AC:
129
AN:
4822
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10614
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00506
AC:
344
AN:
67976
Other (OTH)
AF:
0.0411
AC:
87
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
366
732
1099
1465
1831
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0106
Hom.:
13
Bravo
AF:
0.0632
Asia WGS
AF:
0.0480
AC:
167
AN:
3478
EpiCase
AF:
0.00611
EpiControl
AF:
0.00516

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital dyserythropoietic anemia, type I Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Anemia, congenital dyserythropoietic, type 1a Benign:1
Nov 08, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
5.5
DANN
Benign
0.68
PhyloP100
-0.042
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12594325; hg19: chr15-43028511; COSMIC: COSV51177740; COSMIC: COSV51177740; API